1. Home
  2. MNKD vs SRCE Comparison

MNKD vs SRCE Comparison

Compare MNKD & SRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • SRCE
  • Stock Information
  • Founded
  • MNKD 1991
  • SRCE 1863
  • Country
  • MNKD United States
  • SRCE United States
  • Employees
  • MNKD N/A
  • SRCE N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • SRCE Major Banks
  • Sector
  • MNKD Health Care
  • SRCE Finance
  • Exchange
  • MNKD Nasdaq
  • SRCE Nasdaq
  • Market Cap
  • MNKD 1.7B
  • SRCE 1.5B
  • IPO Year
  • MNKD 2004
  • SRCE N/A
  • Fundamental
  • Price
  • MNKD $5.33
  • SRCE $59.48
  • Analyst Decision
  • MNKD Strong Buy
  • SRCE Hold
  • Analyst Count
  • MNKD 5
  • SRCE 3
  • Target Price
  • MNKD $10.80
  • SRCE $72.00
  • AVG Volume (30 Days)
  • MNKD 4.4M
  • SRCE 79.0K
  • Earning Date
  • MNKD 11-05-2025
  • SRCE 10-23-2025
  • Dividend Yield
  • MNKD N/A
  • SRCE 2.49%
  • EPS Growth
  • MNKD 149.32
  • SRCE 14.53
  • EPS
  • MNKD 0.11
  • SRCE 6.01
  • Revenue
  • MNKD $301,736,000.00
  • SRCE $405,363,000.00
  • Revenue This Year
  • MNKD $14.78
  • SRCE $17.85
  • Revenue Next Year
  • MNKD $19.36
  • SRCE $1.85
  • P/E Ratio
  • MNKD $50.09
  • SRCE $9.91
  • Revenue Growth
  • MNKD 21.48
  • SRCE 9.59
  • 52 Week Low
  • MNKD $3.38
  • SRCE $52.14
  • 52 Week High
  • MNKD $7.63
  • SRCE $68.13
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 49.48
  • SRCE 46.20
  • Support Level
  • MNKD $5.28
  • SRCE $58.79
  • Resistance Level
  • MNKD $5.62
  • SRCE $61.83
  • Average True Range (ATR)
  • MNKD 0.24
  • SRCE 1.36
  • MACD
  • MNKD -0.02
  • SRCE 0.15
  • Stochastic Oscillator
  • MNKD 58.80
  • SRCE 52.33

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About SRCE 1st Source Corporation

1st Source Corp, along with its subsidiary, offers banking services. The bank provides Commercial, Agricultural, and Real Estate Loans, which are given to privately owned business clients mainly located within the regional market areas, Consumer Services that consist of the full range of consumer banking products and services, Trust and Wealth Advisory Services, and Insurance services to individuals and business clients. Its Specialty Finance Group offers financing services for construction equipment, new and pre-owned private and cargo aircraft, and various vehicle types for fleet purposes.

Share on Social Networks: